Tucatinib | hsa00030 | Pentose phosphate pathway | 2.25E-03 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | |
Tucatinib | hsa00040 | Pentose and glucuronate interconversions | 3.53E-02 | 1 | O60701 | UGDH | More | |
Tucatinib | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | |
Tucatinib | hsa00190 | Oxidative phosphorylation | 2.29E-02 | 2 | Q16718, O14521 | NDUFA5, SDHD | More | |
Tucatinib | hsa00220 | Arginine biosynthesis | 3.83E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | |
Tucatinib | hsa00230 | Purine metabolism | 4.93E-02 | 1 | P21589 | NT5E | More | |
Tucatinib | hsa00240 | Pyrimidine metabolism | 1.81E-02 | 1 | P21589 | NT5E | More | |
Tucatinib | hsa00250 | Alanine, aspartate and glutamate metabolism | 8.48E-03 | 2 | Q96RQ9, P15104 | IL4I1, GLUL | More | |
Tucatinib | hsa00270 | Cysteine and methionine metabolism | 2.39E-02 | 2 | Q96RQ9, P40926 | IL4I1, MDH2 | More | |
Tucatinib | hsa00280 | Valine, leucine and isoleucine degradation | 8.48E-03 | 2 | Q96RQ9, P05166 | IL4I1, PCCB | More | |
Tucatinib | hsa00310 | Lysine degradation | 2.71E-03 | 4 | Q9NVH6, Q96KQ7, O15047, P51648 | TMLHE, EHMT2, SETD1A, ALDH3A2 | More | |
Tucatinib | hsa00500 | Starch and sucrose metabolism | 3.06E-05 | 4 | O43451, P46976, P35573, P06737 | MGAM, GYG1, AGL, PYGL | More | |
Tucatinib | hsa00520 | Amino sugar and nucleotide sugar metabolism | 1.04E-03 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | |
Tucatinib | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
Tucatinib | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | |
Tucatinib | hsa00600 | Sphingolipid metabolism | 3.76E-02 | 1 | P15289 | ARSA | More | |
Tucatinib | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 8.72E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | |
Tucatinib | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.46E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | |
Tucatinib | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.62E-05 | 4 | P40925, P40926, P05166, P15104 | MDH1, MDH2, PCCB, GLUL | More | |
Tucatinib | hsa00670 | One carbon pool by folate | 1.33E-02 | 2 | P04818, Q99707 | TYMS, MTR | More | |
Tucatinib | hsa00730 | Thiamine metabolism | 1.55E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
Tucatinib | hsa00760 | Nicotinate and nicotinamide metabolism | 9.09E-03 | 1 | P21589 | NT5E | More | |
Tucatinib | hsa00770 | Pantothenate and CoA biosynthesis | 1.94E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | |
Tucatinib | hsa00830 | Retinol metabolism | 3.93E-02 | 3 | P00352, Q9BPW9, O75911 | ALDH1A1, DHRS9, DHRS3 | More | |
Tucatinib | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Tucatinib | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
Tucatinib | hsa00983 | Drug metabolism - other enzymes | 3.32E-02 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | |
Tucatinib | hsa01100 | Metabolic pathways | 3.18E-03 | 40 | Q9NR34, P05089, Q9UJ14, P15104, Q96DU7, P32320, Q08828, Q02153, P22748, P40926, P55809, P06280, Q16875, O43286, O43451, P05186, P24666, Q86XP1, Q96RQ9, Q9HCC0, P33121, Q9UHK6, P57054, Q9UNP4, Q9H4F1, Q9BX95, Q9BRR6, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, P05166, P12074, P05496, O15239, O15047, Q9NVH6 | MAN1C1, ARG1, GGTL3, GLUL, ITPKC, CDA, ADCY1, GUCY1B3, CA4, MDH2, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, DGKH, IL4I1, MCCC2, ACSL1, AMACR, PIGP, ST3GAL5, ST6GALNAC4, SGPP1, ADPGK, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, PCCB, COX6A1, ATP5G1, NDUFA1, SETD1A, TMLHE | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | -0.717 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P15104 | GLUL | Glutamine synthetase | -0.718 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q96DU7 | ITPKC | Inositol-trisphosphate 3-kinase C | 0.879 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q08828 | ADCY1 | Adenylate cyclase type 1 | -0.748 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q02153 | GUCY1B3 | Guanylate cyclase soluble subunit beta-1 | 0.847 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | -0.731 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q86XP1 | DGKH | Diacylglycerol kinase eta | 0.804 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q96RQ9 | IL4I1 | L-amino-acid oxidase | 0.761 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | 0.839 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9H4F1 | ST6GALNAC4 | Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase | -0.785 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9BRR6 | ADPGK | ADP-dependent glucokinase | -0.71 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P05166 | PCCB | Propionyl-CoA carboxylase beta chain, mitochondrial | -0.714 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | -0.715 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | -0.815 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | -0.834 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15047 | SETD1A | Histone-lysine N-methyltransferase SETD1A | -0.831 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | 0.74 |
|
Tucatinib | hsa01230 | Biosynthesis of amino acids | 3.21E-02 | 4 | P51854, P60891, P05089, P37837 | TKTL1, PRPS1, ARG1, TALDO1 | More | |
Tucatinib | hsa01240 | Biosynthesis of cofactors | 2.05E-02 | 2 | P36551, O60701 | CPOX, UGDH | More | |
Tucatinib | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 3.18E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Tucatinib | hsa01522 | Endocrine resistance | 4.47E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Tucatinib | hsa01523 | Antifolate resistance | 1.88E-03 | 4 | P41440, Q92820, P04818, P01375 | SLC19A1, GGH, TYMS, TNF | More | |
Tucatinib | hsa01524 | Platinum drug resistance | 4.78E-02 | 1 | P31751 | AKT2 | More | |
Tucatinib | hsa02010 | ABC transporters | 1.98E-03 | 3 | P45844, P08183, Q8IZY2 | ABCG1, ABCB1, ABCA7 | More | |
Tucatinib | hsa03020 | RNA polymerase | 3.00E-02 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | |
Tucatinib | hsa03022 | Basal transcription factors | 2.68E-04 | 3 | O00268, Q5H9L4, Q15544 | TAF4, TAF7L, TAF11 | More | |
Tucatinib | hsa03040 | Spliceosome | 7.72E-06 | 13 | O60508, P17844, P08579, P26368, P51991, P61978, Q13595, Q01130, P84103, Q13243, P11142, Q9Y2W2, O75643 | CDC40, DDX5, SNRPB2, U2AF2, HNRPA3, HNRPK, TRA2A, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, ASCC3L1 | More | |
Tucatinib | hsa03060 | Protein export | 4.42E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | |
Tucatinib | hsa03320 | PPAR signaling pathway | 4.33E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | |
Tucatinib | hsa03430 | Mismatch repair | 4.38E-02 | 1 | P20585 | MSH3 | More | |
Tucatinib | hsa03460 | Fanconi anemia pathway | 2.71E-02 | 1 | O94782 | USP1 | More | |
Tucatinib | hsa04010 | MAPK signaling pathway | 1.69E-03 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Tucatinib | hsa04012 | ErbB signaling pathway | 6.63E-03 | 4 | P16333, P19174, P01106, P04049 | NCK1, PLCG1, MYC, RAF1 | More | |
Tucatinib | hsa04014 | Ras signaling pathway | 2.30E-05 | 4 | P04049, P31751, P08069, P0DP23 | RAF1, AKT2, IGF1R, CALM1 | More | |
Tucatinib | hsa04015 | Rap1 signaling pathway | 3.20E-07 | 6 | P04049, P08069, P06213, O00522, P31751, P0DP23 | RAF1, IGF1R, INSR, KRIT1, AKT2, CALM1 | More | |
Tucatinib | hsa04022 | cGMP-PKG signaling pathway | 2.62E-04 | 3 | P04049, P31751, P0DP23 | RAF1, AKT2, CALM1 | More | |
Tucatinib | hsa04024 | cAMP signaling pathway | 1.30E-04 | 3 | P31751, P0DP23, P04049 | AKT2, CALM1, RAF1 | More | |
Tucatinib | hsa04060 | Cytokine-cytokine receptor interaction | 8.46E-04 | 14 | P14784, P27930, P14778, P37173, P26842, Q06643, Q13651, P78552, P25024, Q9UBD3, P47992, P09341, P80075, P01730 | IL2RB, IL1R2, IL1R1, TGFBR2, CD27, LTB, IL10RA, IL13RA1, CXCR1, XCL2, XCL1, CXCL1, CCL8, CD4 | More | |
Tucatinib | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.32E-02 | 6 | P09341, P25024, P47992, Q9UBD3, Q13651, P14784 | CXCL1, CXCR1, XCL1, XCL2, IL10RA, IL2RB | More | |
Tucatinib | hsa04062 | Chemokine signaling pathway | 2.83E-03 | 10 | P25024, P09341, P47992, Q9UBD3, P07948, P63218, P50151, P43250, Q08881, P04049 | CXCR1, CXCL1, XCL1, XCL2, LYN, GNG5, GNG10, GRK6, ITK, RAF1 | More | |
Tucatinib | hsa04064 | NF-kappa B signaling pathway | 9.72E-06 | 16 | O00463, P14778, P01584, P01375, Q04759, Q13077, Q16548, P07948, P06239, Q8WV28, P63279, P24522, Q8NHW4, P09341, Q06643, Q9NQC7 | TRAF5, IL1R1, IL1B, TNF, PRKCQ, TRAF1, BCL2A1, LYN, LCK, BLNK, UBE2I, GADD45A, CCL4L2, CXCL1, LTB, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q04759 | PRKCQ | Protein kinase C theta type | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P06239 | LCK | Tyrosine-protein kinase Lck | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.718 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.73 | Q04759 | PRKCQ | Protein kinase C theta type | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.76 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.875 | P06239 | LCK | Tyrosine-protein kinase Lck | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.701 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q8WV28 | BLNK | B-cell linker protein | -0.816 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.756 | Q04759 | PRKCQ | Protein kinase C theta type | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.846 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.796 | P06239 | LCK | Tyrosine-protein kinase Lck | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.724 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | Q04759 | PRKCQ | Protein kinase C theta type | P09341 | CXCL1 | Growth-regulated alpha protein | -0.885 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | P06239 | LCK | Tyrosine-protein kinase Lck | P09341 | CXCL1 | Growth-regulated alpha protein | -0.805 | P06239 | LCK | Tyrosine-protein kinase Lck | Q06643 | LTB | Lymphotoxin-beta | 0.846 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.825 |
|
Tucatinib | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Tucatinib | hsa04068 | FoxO signaling pathway | 3.80E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Tucatinib | hsa04070 | Phosphatidylinositol signaling system | 1.53E-02 | 2 | Q86XP1, Q96DU7 | DGKH, ITPKC | More | |
Tucatinib | hsa04071 | Sphingolipid signaling pathway | 2.16E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa04072 | Phospholipase D signaling pathway | 2.82E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa04110 | Cell cycle | 8.83E-05 | 8 | Q9UBD5, P06493, O60566, Q14683, P30304, P33981, P42773, P01106 | ORC3, CDK1, BUB1B, SMC1A, CDC25A, TTK, CDKN2C, MYC | More | |
Tucatinib | hsa04114 | Oocyte meiosis | 1.45E-04 | 6 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0, P08069 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4, IGF1R | More | |
Tucatinib | hsa04120 | Ubiquitin mediated proteolysis | 4.82E-03 | 2 | Q9UBT2, Q14669 | SAE2, TRIP12 | More | |
Tucatinib | hsa04140 | Autophagy - animal | 7.72E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | |
Tucatinib | hsa04141 | Protein processing in endoplasmic reticulum | 1.91E-03 | 6 | P18848, Q15437, Q99941, P11142, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, HSPA8, HSP90AA1, SAR1A | More | |
Tucatinib | hsa04142 | Lysosome | 1.46E-02 | 7 | P06865, P22304, P38571, Q13510, P07602, Q9NRA2, P61916 | HEXA, IDS, LIPA, ASAH1, PSAP, SLC17A5, NPC2 | More | |
Tucatinib | hsa04144 | Endocytosis | 1.13E-03 | 14 | Q13191, P0DMV8, P11142, Q9H444, O75351, P62491, P25024, Q96B97, P43250, Q15438, Q14161, P14784, Q9UMY4, Q9Y5X3 | CBLB, HSPA1A, HSPA8, CHMP4B, VPS4B, RAB11A, CXCR1, SH3KBP1, GRK6, PSCD1, GIT2, IL2RB, SNX12, SNX5 | More | |
Tucatinib | hsa04150 | mTOR signaling pathway | 5.20E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | |
Tucatinib | hsa04151 | PI3K-Akt signaling pathway | 3.91E-03 | 7 | P62753, P27348, P07900, P22105, Q99941, P18848, O00141 | RPS6, YWHAQ, HSP90AA1, TNXB, CREBL1, ATF4, SGK | More | |
Tucatinib | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Tucatinib | hsa04210 | Apoptosis | 2.16E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa04211 | Longevity regulating pathway | 5.33E-03 | 4 | P08069, P51828, Q99941, P18848 | IGF1R, ADCY7, CREBL1, ATF4 | More | |
Tucatinib | hsa04213 | Longevity regulating pathway - multiple species | 8.54E-03 | 4 | P08069, Q08828, P51828, P0DMV8 | IGF1R, ADCY1, ADCY7, HSPA1A | More | |
Tucatinib | hsa04217 | Necroptosis | 7.34E-03 | 5 | P01568, Q13546, P07384, Q6FI13, P10415 | IFNA21, RIPK1, CAPN1, H2AC18; H2AC19, BCL2 | More | |
Tucatinib | hsa04218 | Cellular senescence | 1.43E-04 | 3 | P31751, P04049, P0DP23 | AKT2, RAF1, CALM1 | More | |
Tucatinib | hsa04261 | Adrenergic signaling in cardiomyocytes | 6.22E-04 | 6 | P51828, P31751, Q99941, P18848, P0DP23, Q13557 | ADCY7, AKT2, CREBL1, ATF4, CALM1, CAMK2D | More | |
Tucatinib | hsa04270 | Vascular smooth muscle contraction | 2.27E-03 | 7 | P0DP23, P04049, Q08828, P51828, P35579, P35749, P35318 | CALM1, RAF1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | |
Tucatinib | hsa04330 | Notch signaling pathway | 6.65E-03 | 3 | Q92542, P49768, P46531 | NCSTN, PSEN1, NOTCH1 | More | |
Tucatinib | hsa04360 | Axon guidance | 2.49E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa04370 | VEGF signaling pathway | 1.94E-06 | 5 | P16298, P31751, Q05397, Q02750, P04049 | PPP3CB, AKT2, PTK2, MAP2K1, RAF1 | More | |
Tucatinib | hsa04371 | Apelin signaling pathway | 1.43E-04 | 3 | P31751, P04049, P0DP23 | AKT2, RAF1, CALM1 | More | |
Tucatinib | hsa04380 | Osteoclast differentiation | 2.72E-04 | 8 | Q9NQC7, Q9UQC2, Q16539, P31751, P14778, O75015, P01375, Q8N149 | CYLD, GAB2, MAPK14, AKT2, IL1R1, FCGR3B, TNF, LILRA2 | More | |
Tucatinib | hsa04392 | Hippo signaling pathway - multiple species | 3.01E-02 | 1 | Q6V0I7 | FAT4 | More | |
Tucatinib | hsa04510 | Focal adhesion | 1.18E-03 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Tucatinib | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | |
Tucatinib | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | |
Tucatinib | hsa04540 | Gap junction | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.61E-03 | 5 | Q13873, P04049, Q02750, P08069, Q86SE9 | BMPR2, RAF1, MAP2K1, IGF1R, PCGF5 | More | |
Tucatinib | hsa04610 | Complement and coagulation cascades | 1.14E-05 | 2 | P00734, P0C0L4 | F2, C4A | More | |
Tucatinib | hsa04612 | Antigen processing and presentation | 2.28E-04 | 9 | P13765, P48382, P01730, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, CD4, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | |
Tucatinib | hsa04613 | Neutrophil extracellular trap formation | 2.09E-04 | 8 | P04049, P04908, Q93077, P62807, O60814, P68431, O43315, Q16539 | RAF1, H2AC4; H2AC8, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AQP9, MAPK14 | More | |
Tucatinib | hsa04620 | Toll-like receptor signaling pathway | 4.78E-02 | 1 | P31751 | AKT2 | More | |
Tucatinib | hsa04621 | NOD-like receptor signaling pathway | 2.32E-03 | 13 | Q14643, P10599, Q9H1Y0, P43490, O00463, P29728, Q05823, P01375, P09341, P49913, P59665, P59666, P12838 | ITPR1, TXN, ATG5, PBEF1, TRAF5, OAS2, RNASEL, TNF, CXCL1, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | |
Tucatinib | hsa04622 | RIG-I-like receptor signaling pathway | 1.81E-02 | 1 | Q9NQC7 | CYLD | More | |
Tucatinib | hsa04623 | Cytosolic DNA-sensing pathway | 2.02E-04 | 4 | P01584, P01568, Q13546, Q8NHW4 | IL1B, IFNA21, RIPK1, CCL4L2 | More | |
Tucatinib | hsa04625 | C-type lectin receptor signaling pathway | 2.59E-05 | 8 | Q9ULY5, P04049, Q9NQC7, P20749, P01375, P31751, P0DP23, Q16539 | CLEC4E, RAF1, CYLD, BCL3, TNF, AKT2, CALM1, MAPK14 | More | |
Tucatinib | hsa04630 | JAK-STAT signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa04640 | Hematopoietic cell lineage | 5.73E-06 | 12 | P13612, P14778, P27930, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB, TNF | More | |
Tucatinib | hsa04650 | Natural killer cell mediated cytotoxicity | 2.24E-08 | 14 | P16298, P50591, P01375, P06239, O60880, P20963, Q02750, P04049, Q13241, P26718, O14931, O75015, P26717, P26715 | PPP3CB, TNFSF10, TNF, LCK, SH2D1A, CD247, MAP2K1, RAF1, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | |
Tucatinib | hsa04657 | IL-17 signaling pathway | 1.88E-03 | 6 | O00463, Q16539, P49841, P09341, P14780, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, TNF | More | |
Tucatinib | hsa04658 | Th1 and Th2 cell differentiation | 3.99E-11 | 12 | Q04759, P07766, P20963, P09693, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q04759 | PRKCQ | Protein kinase C theta type | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.746 | Q04759 | PRKCQ | Protein kinase C theta type | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.867 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | Q04759 | PRKCQ | Protein kinase C theta type | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.843 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.855 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.85 |
|
Tucatinib | hsa04659 | Th17 cell differentiation | 3.12E-10 | 14 | Q04759, P01730, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, Q13485, P08238, P07766, P09693, P20963 | PRKCQ, CD4, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.714 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | Q04759 | PRKCQ | Protein kinase C theta type | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.8 | Q04759 | PRKCQ | Protein kinase C theta type | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.843 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | Q04759 | PRKCQ | Protein kinase C theta type | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.867 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.729 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.782 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 |
|
Tucatinib | hsa04660 | T cell receptor signaling pathway | 4.93E-08 | 12 | P01375, Q04759, O95267, Q08881, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, P04049 | TNF, PRKCQ, RASGRP1, ITK, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, RAF1 | More | |
Tucatinib | hsa04662 | B cell receptor signaling pathway | 8.03E-04 | 6 | P31751, P42338, P60033, P07948, Q8N149, P04049 | AKT2, PIK3CB, CD81, LYN, LILRA2, RAF1 | More | |
Tucatinib | hsa04664 | Fc epsilon RI signaling pathway | 1.50E-03 | 5 | P01375, P31751, Q16539, Q9UQC2, P04049 | TNF, AKT2, MAPK14, GAB2, RAF1 | More | |
Tucatinib | hsa04666 | Fc gamma R-mediated phagocytosis | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | |
Tucatinib | hsa04713 | Circadian entrainment | 9.20E-03 | 4 | Q13557, Q02153, P61952, Q08828 | CAMK2D, GUCY1B3, GNG11, ADCY1 | More | |
Tucatinib | hsa04714 | Thermogenesis | 6.01E-04 | 8 | Q16539, P51828, P62753, P33121, P12074, O15239, Q16718, O14521 | MAPK14, ADCY7, RPS6, ACSL1, COX6A1, NDUFA1, NDUFA5, SDHD | More | |
Tucatinib | hsa04720 | Long-term potentiation | 4.88E-03 | 4 | P16298, P51812, Q02750, P04049 | PPP3CB, RPS6KA3, MAP2K1, RAF1 | More | |
Tucatinib | hsa04722 | Neurotrophin signaling pathway | 2.58E-06 | 5 | Q05655, P31751, P04049, P52566, P0DP23 | PRKCD, AKT2, RAF1, ARHGDIB, CALM1 | More | |
Tucatinib | hsa04724 | Glutamatergic synapse | 2.22E-02 | 4 | O15399, P63218, P50151, P15104 | GRIN2D, GNG5, GNG10, GLUL | More | |
Tucatinib | hsa04725 | Cholinergic synapse | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | |
Tucatinib | hsa04726 | Serotonergic synapse | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa04727 | GABAergic synapse | 1.62E-03 | 6 | Q08828, P63218, P50151, P61952, P15104, Q15111 | ADCY1, GNG5, GNG10, GNG11, GLUL, PLCL1 | More | |
Tucatinib | hsa04728 | Dopaminergic synapse | 1.96E-03 | 5 | P31751, Q99941, P18848, Q13557, P0DP23 | AKT2, CREBL1, ATF4, CAMK2D, CALM1 | More | |
Tucatinib | hsa04730 | Long-term depression | 1.25E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | |
Tucatinib | hsa04740 | Olfactory transduction | 2.41E-02 | 1 | P0DP23 | CALM1 | More | |
Tucatinib | hsa04744 | Phototransduction | 1.81E-02 | 1 | P0DP23 | CALM1 | More | |
Tucatinib | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.01E-02 | 4 | P01584, Q08828, P51828, P0DP23 | IL1B, ADCY1, ADCY7, CALM1 | More | |
Tucatinib | hsa04810 | Regulation of actin cytoskeleton | 3.81E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa04910 | Insulin signaling pathway | 2.40E-05 | 3 | P0DP23, P04049, P31751 | CALM1, RAF1, AKT2 | More | |
Tucatinib | hsa04911 | Insulin secretion | 5.41E-05 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | |
Tucatinib | hsa04912 | GnRH signaling pathway | 3.36E-03 | 4 | P51828, P18848, Q13557, P04049 | ADCY7, ATF4, CAMK2D, RAF1 | More | |
Tucatinib | hsa04913 | Ovarian steroidogenesis | 8.40E-04 | 2 | P06213, P08069 | INSR, IGF1R | More | |
Tucatinib | hsa04914 | Progesterone-mediated oocyte maturation | 5.28E-05 | 6 | P08069, Q17RY0, Q9Y6D9, P51812, Q02750, P04049 | IGF1R, CPEB4, MAD1L1, RPS6KA3, MAP2K1, RAF1 | More | |
Tucatinib | hsa04915 | Estrogen signaling pathway | 1.26E-05 | 11 | P04049, Q99941, P18848, Q08828, P51828, P31751, P07900, P0DMV8, P11142, P0DP23, Q15788 | RAF1, CREBL1, ATF4, ADCY1, ADCY7, AKT2, HSP90AA1, HSPA1A, HSPA8, CALM1, NCOA1 | More | |
Tucatinib | hsa04916 | Melanogenesis | 1.47E-03 | 2 | P0DP23, P04049 | CALM1, RAF1 | More | |
Tucatinib | hsa04917 | Prolactin signaling pathway | 3.49E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | |
Tucatinib | hsa04918 | Thyroid hormone synthesis | 1.69E-03 | 4 | P51828, Q99941, P18848, P02768 | ADCY7, CREBL1, ATF4, ALB | More | |
Tucatinib | hsa04919 | Thyroid hormone signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa04920 | Adipocytokine signaling pathway | 4.19E-02 | 1 | P31751 | AKT2 | More | |
Tucatinib | hsa04921 | Oxytocin signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa04922 | Glucagon signaling pathway | 1.79E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Tucatinib | hsa04923 | Regulation of lipolysis in adipocytes | 1.84E-03 | 2 | P06213, P31751 | INSR, AKT2 | More | |
Tucatinib | hsa04924 | Renin secretion | 3.01E-02 | 1 | P0DP23 | CALM1 | More | |
Tucatinib | hsa04925 | Aldosterone synthesis and secretion | 1.69E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | |
Tucatinib | hsa04926 | Relaxin signaling pathway | 7.01E-03 | 4 | Q99941, P18848, P51828, P04049 | CREBL1, ATF4, ADCY7, RAF1 | More | |
Tucatinib | hsa04927 | Cortisol synthesis and secretion | 4.16E-03 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | |
Tucatinib | hsa04928 | Parathyroid hormone synthesis, secretion and action | 3.95E-03 | 4 | P51828, P04049, Q99941, P18848 | ADCY7, RAF1, CREBL1, ATF4 | More | |
Tucatinib | hsa04929 | GnRH secretion | 1.87E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | |
Tucatinib | hsa04930 | Type II diabetes mellitus | 1.48E-03 | 2 | P06213, Q05655 | INSR, PRKCD | More | |
Tucatinib | hsa04932 | Non-alcoholic fatty liver disease | 9.65E-04 | 9 | P49841, O43521, O75460, P01584, P13073, P12074, Q16718, O95298, O14521 | GSK3B, BCL2L11, ERN1, IL1B, COX4I1, COX6A1, NDUFA5, NDUFC2, SDHD | More | |
Tucatinib | hsa04934 | Cushing syndrome | 3.32E-05 | 6 | Q99941, P18848, Q08828, P51828, O15169, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, AXIN1, CAMK2D | More | |
Tucatinib | hsa04935 | Growth hormone synthesis, secretion and action | 5.33E-03 | 4 | P51828, P04049, Q99941, P18848 | ADCY7, RAF1, CREBL1, ATF4 | More | |
Tucatinib | hsa04960 | Aldosterone-regulated sodium reabsorption | 3.14E-02 | 1 | P06213 | INSR | More | |
Tucatinib | hsa04964 | Proximal tubule bicarbonate reclamation | 4.48E-02 | 1 | P00918 | CA2 | More | |
Tucatinib | hsa04966 | Collecting duct acid secretion | 4.48E-02 | 1 | P00918 | CA2 | More | |
Tucatinib | hsa04970 | Salivary secretion | 1.11E-02 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
Tucatinib | hsa04971 | Gastric acid secretion | 4.78E-02 | 1 | P0DP23 | CALM1 | More | |
Tucatinib | hsa04973 | Carbohydrate digestion and absorption | 2.41E-02 | 1 | P31751 | AKT2 | More | |
Tucatinib | hsa04976 | Bile secretion | 3.14E-03 | 5 | O43315, Q08828, P51828, P08183, Q14032 | AQP9, ADCY1, ADCY7, ABCB1, BAAT | More | |
Tucatinib | hsa05010 | Alzheimer disease | 9.96E-04 | 11 | P49768, Q92542, O15239, P05496, P12074, Q00535, P0DP23, Q12933, O15169, P31751, P43686 | PSEN1, NCSTN, NDUFA1, ATP5G1, COX6A1, CDK5, CALM1, TRAF2, AXIN1, AKT2, PSMC4 | More | |
Tucatinib | hsa05016 | Huntington disease | 2.46E-02 | 9 | O95298, P13073, P12074, P24928, P30876, P62487, O75460, P28070, O00232 | NDUFC2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, ERN1, PSMB4, PSMD12 | More | |
Tucatinib | hsa05017 | Spinocerebellar ataxia | 2.22E-02 | 4 | Q92915, O15399, P42338, P21796 | FGF14, GRIN2D, PIK3CB, VDAC1 | More | |
Tucatinib | hsa05020 | Prion disease | 3.80E-02 | 4 | Q16718, O14521, P49841, Q16539 | NDUFA5, SDHD, GSK3B, MAPK14 | More | |
Tucatinib | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.30E-05 | 19 | P49841, O15239, Q16718, O14521, P12074, P05496, Q06055, Q12933, Q13561, Q16539, Q00535, O15169, P49768, Q08752, O15020, P0DP23, Q13557, P62987, P43686 | GSK3B, NDUFA1, NDUFA5, SDHD, COX6A1, ATP5G1, ATP5G2, TRAF2, DCTN2, MAPK14, CDK5, AXIN1, PSEN1, PPID, SPTBN2, CALM1, CAMK2D, UBA52, PSMC4 | More | |
Tucatinib | hsa05030 | Cocaine addiction | 6.96E-03 | 3 | Q00535, Q99941, P18848 | CDK5, CREBL1, ATF4 | More | |
Tucatinib | hsa05031 | Amphetamine addiction | 9.24E-04 | 4 | P0DP23, Q13557, Q99941, P18848 | CALM1, CAMK2D, CREBL1, ATF4 | More | |
Tucatinib | hsa05034 | Alcoholism | 2.78E-04 | 5 | P04049, Q93077, P62807, O60814, P68431 | RAF1, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Tucatinib | hsa05100 | Bacterial invasion of epithelial cells | 2.85E-02 | 3 | Q14141, Q05397, Q96JJ3 | SEPT6, PTK2, ELMO2 | More | |
Tucatinib | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.45E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | |
Tucatinib | hsa05131 | Shigellosis | 2.57E-02 | 2 | Q05655, P07737 | PRKCD, PFN1 | More | |
Tucatinib | hsa05132 | Salmonella infection | 4.80E-03 | 3 | P04049, P84095, P07737 | RAF1, RHOG, PFN1 | More | |
Tucatinib | hsa05133 | Pertussis | 2.35E-03 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | |
Tucatinib | hsa05134 | Legionellosis | 2.82E-02 | 3 | P01584, Q9NR31, P0DMV8 | IL1B, SAR1A, HSPA1A | More | |
Tucatinib | hsa05135 | Yersinia infection | 3.29E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | |
Tucatinib | hsa05140 | Leishmaniasis | 2.69E-02 | 5 | O75015, P13765, O60603, P49006, Q16539 | FCGR3B, HLA-DOB, TLR2, MARCKSL1, MAPK14 | More | |
Tucatinib | hsa05143 | African trypanosomiasis | 4.81E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
Tucatinib | hsa05144 | Malaria | 3.12E-02 | 4 | P60033, P01375, P35443, P26718 | CD81, TNF, THBS4, KLRK1 | More | |
Tucatinib | hsa05146 | Amoebiasis | 1.74E-05 | 9 | P09341, P14778, P27930, P01375, O60603, P05089, P22694, P12814, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, ACTN1, CTSG | More | |
Tucatinib | hsa05150 | Staphylococcus aureus infection | 1.48E-04 | 9 | P0C0L4, P21730, P21462, O75015, P13646, P59665, P59666, P12838, P49913 | C4A, C5AR1, FPR1, FCGR3B, KRT13, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | |
Tucatinib | hsa05152 | Tuberculosis | 6.23E-04 | 3 | P04049, P0DP23, P31751 | RAF1, CALM1, AKT2 | More | |
Tucatinib | hsa05160 | Hepatitis C | 4.55E-03 | 5 | P52630, P60033, Q9NZJ5, P04049, P49841 | STAT2, CD81, EIF2AK3, RAF1, GSK3B | More | |
Tucatinib | hsa05161 | Hepatitis B | 5.33E-03 | 4 | P04049, Q99941, P18848, P27348 | RAF1, CREBL1, ATF4, YWHAQ | More | |
Tucatinib | hsa05162 | Measles | 3.18E-02 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | |
Tucatinib | hsa05163 | Human cytomegalovirus infection | 1.11E-04 | 17 | P31751, P04049, P01375, Q14643, P0DP23, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, Q13651, P25025, Q16539, P04637, O00463 | AKT2, RAF1, TNF, ITPR1, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, IL10RA, CXCR2, MAPK14, TP53, TRAF5 | More | |
Tucatinib | hsa05164 | Influenza A | 3.65E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 2.62E-04 | 3 | P31751, P04049, P0DP23 | AKT2, RAF1, CALM1 | More | |
Tucatinib | hsa05169 | Epstein-Barr virus infection | 5.59E-04 | 12 | P13765, P01106, Q13547, O00463, P07948, Q13761, P24522, P01375, P29728, P07766, P09693, P20963 | HLA-DOB, MYC, HDAC1, TRAF5, LYN, RUNX3, GADD45A, TNF, OAS2, CD3E, CD3G, CD247 | More | |
Tucatinib | hsa05170 | Human immunodeficiency virus 1 infection | 3.77E-04 | 3 | P31751, P04049, P0DP23 | AKT2, RAF1, CALM1 | More | |
Tucatinib | hsa05200 | Pathways in cancer | 3.07E-02 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Tucatinib | hsa05202 | Transcriptional misregulation in cancer | 3.47E-03 | 11 | P14780, P27930, Q15744, Q16548, P08069, P05164, P12838, P08246, Q9C0K0, Q13547, P24522 | MMP9, IL1R2, CEBPE, BCL2A1, IGF1R, MPO, DEFA4, ELA2, BCL11B, HDAC1, GADD45A | More | |
Tucatinib | hsa05203 | Viral carcinogenesis | 2.63E-03 | 7 | Q99941, P18848, P27348, Q15283, P61978, P62807, O60814 | CREBL1, ATF4, YWHAQ, RASA2, HNRPK, HIST1H2BC, H2BC12 | More | |
Tucatinib | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Tucatinib | hsa05205 | Proteoglycans in cancer | 1.18E-03 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Tucatinib | hsa05206 | MicroRNAs in cancer | 3.15E-02 | 1 | P04049 | RAF1 | More | |
Tucatinib | hsa05210 | Colorectal cancer | 2.55E-03 | 3 | Q9UKG1, P04049, P37173 | APPL1, RAF1, TGFBR2 | More | |
Tucatinib | hsa05211 | Renal cell carcinoma | 1.29E-03 | 2 | P31751, P04049 | AKT2, RAF1 | More | |
Tucatinib | hsa05212 | Pancreatic cancer | 1.29E-03 | 2 | P31751, P04049 | AKT2, RAF1 | More | |
Tucatinib | hsa05213 | Endometrial cancer | 8.16E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | |
Tucatinib | hsa05214 | Glioma | 1.14E-07 | 4 | P08069, P0DP23, P04049, P31751 | IGF1R, CALM1, RAF1, AKT2 | More | |
Tucatinib | hsa05215 | Prostate cancer | 1.65E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | |
Tucatinib | hsa05218 | Melanoma | 5.24E-06 | 3 | P08069, P31751, P04049 | IGF1R, AKT2, RAF1 | More | |
Tucatinib | hsa05219 | Bladder cancer | 5.65E-03 | 3 | P14780, P04637, P04049 | MMP9, TP53, RAF1 | More | |
Tucatinib | hsa05220 | Chronic myeloid leukemia | 9.63E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | |
Tucatinib | hsa05221 | Acute myeloid leukemia | 8.16E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | |
Tucatinib | hsa05222 | Small cell lung cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | |
Tucatinib | hsa05223 | Non-small cell lung cancer | 3.49E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | |
Tucatinib | hsa05224 | Breast cancer | 2.75E-03 | 6 | P04049, P08069, P49841, Q92837, P04637, P24522 | RAF1, IGF1R, GSK3B, FRAT1, TP53, GADD45A | More | |
Tucatinib | hsa05225 | Hepatocellular carcinoma | 1.65E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Tucatinib | hsa05226 | Gastric cancer | 6.81E-04 | 2 | P04049, P31751 | RAF1, AKT2 | More | |
Tucatinib | hsa05230 | Central carbon metabolism in cancer | 1.12E-03 | 2 | P04049, P31751 | RAF1, AKT2 | More | |
Tucatinib | hsa05231 | Choline metabolism in cancer | 4.44E-03 | 4 | P04049, Q9Y259, P19174, P49619 | RAF1, CHKB, PLCG1, DGKG | More | |
Tucatinib | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.29E-05 | 10 | O95267, P07766, P20963, P09693, P06239, P04049, O60603, Q04759, Q16539, P01730 | RASGRP1, CD3E, CD247, CD3G, LCK, RAF1, TLR2, PRKCQ, MAPK14, CD4 | More | |
Tucatinib | hsa05310 | Asthma | 8.13E-03 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | |
Tucatinib | hsa05321 | Inflammatory bowel disease | 2.80E-04 | 6 | P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | |
Tucatinib | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Tucatinib | hsa05332 | Graft-versus-host disease | 6.88E-04 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | |
Tucatinib | hsa05340 | Primary immunodeficiency | 2.19E-02 | 4 | P01730, P01732, P07766, P06239 | CD4, CD8A, CD3E, LCK | More | |
Tucatinib | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.48E-02 | 1 | P54284 | CACNB3 | More | |
Tucatinib | hsa05414 | Dilated cardiomyopathy | 4.55E-02 | 2 | P54284, P26678 | CACNB3, PLN | More | |
Tucatinib | hsa05415 | Diabetic cardiomyopathy | 1.46E-03 | 6 | P30405, Q16718, O14521, Q16539, P49841, P37173 | PPIF, NDUFA5, SDHD, MAPK14, GSK3B, TGFBR2 | More | |
Tucatinib | hsa05418 | Fluid shear stress and atherosclerosis | 1.27E-05 | 10 | Q16539, P31751, Q14145, P10599, P14780, P01375, P04637, P14778, P27930, P0DP23 | MAPK14, AKT2, KEAP1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2, CALM1 | More | |